Evaluation of the Bronchoprotective Effect of Arformoterol in Children With Exercise Induced Bronchospasm
Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 15 Dec 2015
At a glance
- Drugs Arformoterol (Primary) ; Formoterol
- Indications Exercise-induced asthma
- Focus Therapeutic Use
- 10 Dec 2015 Status changed from discontinued to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
- 09 Dec 2009 Actual patient number (20) added as reported by ClinicalTrials.gov.
- 09 Dec 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.